Cage Bio, Inc. — Form D
Cage Bio, Inc. of SAN CARLOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-28. The offering totals $15.0M, of which $8.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-10-28
- Form: D
- Accession: 0001782671-21-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $8.5M
- Remaining: $6.5M
- Investors: 4
- Date of first sale: 2021-10-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-418868
Issuer
- Name: Cage Bio, Inc.
- CIK: 0001782671
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 733 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Phone: (650) 996 1845
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ravi Srinivasan | Director | Southlake, TX |
| Nitin Joshi | Director | San Carlos, CA |
| Nitin Joshi | Executive Officer | San Carlos, CA |
| Jeff Keyser | Director | San Carlos, CA |
| Samir Mitragotri | Director | San Carlos, CA |
| Ravi Srinivasan | Executive Officer | Southlake, TX |
Other filings by this issuer (4)
More